Biochemical and cell-based assays for characterization of BACE-1 inhibitors
- 3 May 2005
- journal article
- research article
- Published by Elsevier in Analytical Biochemistry
- Vol. 342 (1) , 144-151
- https://doi.org/10.1016/j.ab.2005.04.019
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patientsProceedings of the National Academy of Sciences, 2004
- Human β-Secretase (BACE) and BACE InhibitorsJournal of Medicinal Chemistry, 2003
- Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generationNature Neuroscience, 2001
- BACE1 is the major β-secretase for generation of Aβ peptides by neuronsNature Neuroscience, 2001
- Aβ-Generating EnzymesNeuron, 2000
- Design of Potent Inhibitors for Human Brain Memapsin 2 (β-Secretase)Journal of the American Chemical Society, 2000
- Translating cell biology into therapeutic advances in Alzheimer's diseaseNature, 1999
- Presenilin is required for activity and nuclear access of Notch in DrosophilaNature, 1999
- Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain.Proceedings of the National Academy of Sciences, 1992
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984